Value of Serum Human Epidermal Growth Factor Receptor 2 (HER2)/neu Testing for Early Prediction of Response to HER2/neu-Directed Therapies Is Still an Open One and Deserves Further Study in Large Prospective Trials

被引：11
|
作者：
Ali, Suhail M. [1 ,2 ]
Leitzel, Kim [1 ,2 ]
Lipton, Allan [1 ,2 ]
Carney, Walter P. [3 ]
Koestler, Wolfgang J. [4 ]
机构：
[1] Penn State Univ, Milton S Hershey Med Ctr, Hershey, PA 17033 USA
[2] Lebanon VAMC, Lebanon, PA USA
[3] Oncogene Sci Siemens HealthCare Diagnost, Cambridge, MA USA
[4] Med Univ Vienna, Vienna, Austria
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 36期
关键词：
METASTATIC BREAST-CANCER; TRASTUZUMAB;
D O I：
10.1200/JCO.2009.23.4674
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：e273 / e273
页数：1
相关论文
共 50 条
  • [41] Consensus Guidelines on Human Epidermal Growth Factor Receptor 2 (HER2)-Low Testing in Breast Cancer in Malaysia
    Rajadurai, Pathmanathan
    Ravindran, Sarala
    Lee, Bang Rom
    Pauzi, Suria Hayati Md
    Chiew, Seow Fan
    Teoh, Kean Hooi
    Gopal, Navarasi S. Raja
    Yusof, Mastura Md
    Yip, Cheng Har
    CANCERS, 2024, 16 (13)
  • [42] SAR and QSAR study on the bioactivities of human epidermal growth factor receptor-2 (HER2) inhibitors
    Qu, D.
    Yan, A.
    Zhang, J. S.
    SAR AND QSAR IN ENVIRONMENTAL RESEARCH, 2017, 28 (02) : 111 - 132
  • [43] Differential expression of epidermal growth factor receptor, c-Met, and HER2/neu in chordoma compared with 17 other malignancies
    Weinberger, PM
    Yu, ZW
    Kowalski, D
    Joe, J
    Manger, P
    Psyrri, A
    Sasaki, CT
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2005, 131 (08) : 707 - 711
  • [44] DNA ploidy, cell kinetics, and epidermal growth factor receptor and HER2/neu oncoprotein expression in primary operable breast cancer
    DAgnano, I
    Bucci, B
    Mottolese, M
    Benevolo, M
    Conti, L
    Botti, C
    Vecchione, A
    Casillo, S
    Zupi, G
    BASIS FOR CANCER MANAGEMENT, 1996, 784 : 472 - 481
  • [45] Impact of Human Epidermal Growth Factor Receptor 2 (HER2) Low Status in Response to Neoadjuvant Chemotherapy in Early Breast Cancer
    Alves, Fatima R.
    Gil, Lucia
    de Matos, Leonor Vasconcelos
    Baleiras, Ana
    Vasques, Carolina
    Neves, Maria Teresa
    Ferreira, Andre
    Fontes-Sousa, Mario
    Miranda, Helena
    Martins, Ana
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (02)
  • [46] Exploring mechanisms of acquired resistance to HER2 (human epidermal growth factor receptor 2)-targeted therapies in breast cancer
    Creedon, Helen
    Byron, Adam
    Main, Joanna
    Hayward, Larry
    Klinowska, Teresa
    Brunton, Valerie G.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2014, 42 : 822 - 830
  • [47] Clinical impact of epidermal growth factor receptor (EGFR) coexpression in early breast cancer with human epidermal growth factor receptor 2 (HER2) overexpression
    Park, S.
    Cho, E.
    Shin, Y.
    Hong, S.
    Lee, M.
    Park, Y.
    Nam, S.
    Yang, J.
    Choi, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [48] Human epidermal growth factor receptor 2 (HER2) in gastric cancer: a new therapeutic target
    De Vita, F.
    Giuliani, F.
    Silvestris, N.
    Catalano, G.
    Ciardiello, F.
    Orditura, M.
    CANCER TREATMENT REVIEWS, 2010, 36 : S11 - S15
  • [49] CHARACTERIZATION OF MURINE MONOCLONAL-ANTIBODIES REACTIVE TO EITHER THE HUMAN EPIDERMAL GROWTH-FACTOR RECEPTOR OR HER2 NEU GENE-PRODUCT
    FENDLY, BM
    WINGET, M
    HUDZIAK, RM
    LIPARI, MT
    NAPIER, MA
    ULLRICH, A
    CANCER RESEARCH, 1990, 50 (05) : 1550 - 1558
  • [50] Circulating human epidermal growth factor receptor 2 (HER2) is associated with hyperglycaemia and insulin resistance
    Memon, Ashfaque A.
    Bennet, Louise
    Zoller, Bengt
    Wang, Xiao
    Palmer, Karolina
    Sundquist, Kristina
    Sundquist, Jan
    JOURNAL OF DIABETES, 2015, 7 (03) : 369 - 377
12345